1 - 25 of
98
results
for uniprot:Q80Y89
in citationmapping
| Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Montagna C., Andrechek E.R., Padilla-Nash H., Muller W.J., Ried T. Oncogene 21:890-898(2002) GeneRIF 13866 · Mapped (6) |
| ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Muraoka R.S., Lenferink A.E., Law B., Hamilton E., Brantley D.M., Roebuck L.R., Arteaga C.L. Mol. Cell. Biol. 22:2204-2219(2002) GeneRIF 13866 · Mapped (16) |
| ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. Schroeder J.A., Adriance M.C., McConnell E.J., Thompson M.C., Pockaj B., Gendler S.J. J. Biol. Chem. 277:22692-22698(2002) GeneRIF 13866 · Mapped (23) |
| ErbB2 activation of ESX gene expression. Neve R.M., Ylstra B., Chang C.-H., Albertson D.G., Benz C.C. Oncogene 21:3934-3938(2002) GeneRIF 13866 · UniProtKB (1) · Mapped (16) |
| ErbB2 is required for muscle spindle and myoblast cell survival. Andrechek E.R., Hardy W.R., Girgis-Gabardo A.A., Perry R.L., Butler R., Graham F.L., Kahn R.C., Rudnicki M.A., Muller W.J. Mol. Cell. Biol. 22:4714-4722(2002) GeneRIF 13866 · Mapped (6) |
| Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Ozcelik C., Erdmann B., Pilz B., Wettschureck N., Britsch S., Hubner N., Chien K.R., Birchmeier C., Garratt A.N. Proc. Natl. Acad. Sci. U.S.A. 99:8880-8885(2002) GeneRIF 13866 · Mapped (8) |
| Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Camenisch T.D., Schroeder J.A., Bradley J., Klewer S.E., McDonald J.A. Nat. Med. 8:850-855(2002) GeneRIF 13866 · Mapped (6) |
| Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Janda E., Litos G., Grunert S., Downward J., Beug H. Oncogene 21:5148-5159(2002) GeneRIF 13866 · Mapped (6) |
| ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1. Hulit J., Lee R.J., Russell R.G., Pestell R.G. Biochem. Pharmacol. 64:827-836(2002) GeneRIF 13866 · Mapped (16) |
| Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous system. Crone S.A., Negro A., Trumpp A., Giovannini M., Lee K.F. Neuron 37:29-40(2003) GeneRIF 13866 · Mapped (6) |
| Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. Gil-Henn H., Elson A. J. Biol. Chem. 278:15579-15586(2003) GeneRIF 13866 · UniProtKB (1) · Mapped (10) |
| Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Iwamoto R., Yamazaki S., Asakura M., Takashima S., Hasuwa H., Miyado K., Adachi S., Kitakaze M., Hashimoto K., Raab G. et al. Proc. Natl. Acad. Sci. U.S.A. 100:3221-3226(2003) GeneRIF 13866 · Mapped (23) |
| Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Schmid R.S., McGrath B., Berechid B.E., Boyles B., Marchionni M., Sestan N., Anton E.S. Proc. Natl. Acad. Sci. U.S.A. 100:4251-4256(2003) GeneRIF 13866 · Mapped (14) |
| Erbb2 regulates neuromuscular synapse formation and is essential for muscle spindle development. Leu M., Bellmunt E., Schwander M., Farinas I., Brenner H.R., Muller U. Development 130:2291-2301(2003) GeneRIF 13866 · Mapped (17) |
| Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model. Jeruss J.S., Liu N.X., Chung Y., Magrane G., Waldman F., Edgerton S., Yang X., Thor A.D. Carcinogenesis 24:659-664(2003) GeneRIF 13866 · Mapped (6) |
| The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo. Kim J.Y., Sun Q., Oglesbee M., Yoon S.O. J. Neurosci. 23:5561-5571(2003) GeneRIF 13866 · Mapped (6) |
| Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation. Kumagai T., Katsumata M., Hasegawa A., Furuuchi K., Funakoshi T., Kawase I., Greene M.I. Proc. Natl. Acad. Sci. U.S.A. 100:9220-9225(2003) GeneRIF 13866 · Mapped (6) |
| Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bershtein L.M., Alimova I.N., Tsyrlina E.V., Anisimov V.N. Bull. Exp. Biol. Med. 135:580-581(2003) GeneRIF 13866 · Mapped (12) |
| Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Muraoka R.S., Koh Y., Roebuck L.R., Sanders M.E., Brantley-Sieders D., Gorska A.E., Moses H.L., Arteaga C.L. Mol. Cell. Biol. 23:8691-8703(2003) GeneRIF 13866 · Mapped (6) |
| Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1. Gensler M., Buschbeck M., Ullrich A. J. Biol. Chem. 279:12110-12116(2004) GeneRIF 13866 · Mapped (21) |
| Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression. Gillgrass A., Cardiff R.D., Sharan N., Kannan S., Muller W.J. Oncogene 22:9151-9155(2003) GeneRIF 13866 · Mapped (18) |
| Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2. Tikhomirov O., Carpenter G. J. Biol. Chem. 279:12988-12996(2004) GeneRIF 13866 · Mapped (39) |
| HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway. Herrmann F., Lehr H.A., Drexler I., Sutter G., Hengstler J., Wollscheid U., Seliger B. Cancer Res. 64:215-220(2004) GeneRIF 13866 · Mapped (6) |
| Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway. Makino K., Day C.P., Wang S.C., Li Y.M., Hung M.C. Oncogene 23:3883-3887(2004) GeneRIF 13866 · Mapped (21) |
| Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis. Andrechek E.R., Hardy W.R., Laing M.A., Muller W.J. Proc. Natl. Acad. Sci. U.S.A. 101:4984-4989(2004) GeneRIF 13866 · Mapped (7) |



